Each year, CGT's scientific agenda includes 100+ of the industry's top scientists to present the latest updates on how to improve efficiencies across all phases of Cell & Gene Therapy development and production. This year for the first time, our Head of Marketing Dr Raphael Guebeli is chair of the track "In Vivo Gene Therapy".